CD19 chimeric antigen receptor T-cell therapy improved lung function and skin thickness in patients with severe refractory ...

Large language models, when used alongside human clinical judgement, “substantially” improved diagnostic accuracy among a ...

Self-care and taking time to enjoy “sacred moments” can help reduce burnout and improve work-life balance for physicians, ...

Results presented at the American Association of Hip and Knee Surgeons Annual Meeting showed synthetic THC may not reduce ...

Enpatoran, a first-in-class oral small molecule toll-like receptor 7/8 inhibitor, is superior to placebo in improving mucocutaneous symptoms of cutaneous and systemic lupus, according to data ...

A cementless, anatomic ceramic hip resurfacing device may be safe and effective, with a low all-cause revision rate at 8-year ...

The FDA approved belantamab mafodotin-blmf in combination with bortezomib and dexamethasone for the treatment of certain ...

The FDA declined to approve SYD-101, a low-dose atropine formulation that would have been the first pharmaceutical treatment ...

Women who experience menopause at an earlier age and have a reduction in cardiac function are at increased risk for adverse ...

Topcon Healthcare launched IDHea Inc., a company focused on driving clinical research and oculomics to advance eye care, ...

The FDA has approved once-daily oral Lynkuet for the treatment of moderate to severe hot flashes caused by menopause, ...

Preliminary results presented here showed use of a custom-tailored AI platform may be a feasible option to address ...